User profiles for M. Bosch

Mathieu Bosch

- Verified email at chem.tamu.edu - Cited by 7244

Marta Bosch

- Verified email at ub.edu - Cited by 3398

Miquel Bosch

- Verified email at uic.es - Cited by 2784

Tuning the structure and function of metal–organic frameworks via linker design

…, M Zhang, Q Zhang, T Gentle III, M Bosch… - Chemical Society …, 2014 - pubs.rsc.org
… Its experimental BET surface area can be significantly improved from 526 m 2 g −1 (conventional
activation) to 1560 m 2 g −1 (freeze-drying activation). Its H 2 uptake was also …

Stable metal–organic frameworks: design, synthesis, and applications

S Yuan, L Feng, K Wang, J Pang, M Bosch… - Advanced …, 2018 - Wiley Online Library
… This material demonstrated excellent stability in aqueous solutions of 1 m KF, K 3 PO 4 ,
and Na 2 CO 3 . The N 2 sorption isotherms and PXRD patterns of the treated PCN-602 …

Planning and studying improvement in patient care: the use of theoretical perspectives

RPTM Grol, MC Bosch, MEJL Hulscher… - The Milbank …, 2007 - Wiley Online Library
A consistent finding in articles on quality improvement in health care is that change is difficult
to achieve. According to the research literature, the majority of interventions are targeted at …

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I

ML Coleman, EA Sahai, M Yeo, M Bosch, A Dewar… - Nature cell …, 2001 - nature.com
The execution phase of apoptosis is characterized by marked changes in cell morphology
that include contraction and membrane blebbing. The actin–myosin system has been …

Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial

…, M Bosch, A Ladaria, M Rubio… - Annals of Internal …, 2001 - acpjournals.org
Background: The sleep apnea–hypopnea syndrome is defined by a pathologic number of
respiratory events during sleep (the apnea–hypopnea index, defined as the number of apnea …

Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a …

…, M Schulder, RM Prins, AL Boynton, ML Bosch - JAMA …, 2023 - jamanetwork.com
Bosch reported being employees of and owning shares in Northwest Biotherapeutics, Inc.
Dr Boynton reported having a patent held by Northwest Biotherapeutics. Dr Bosch … Dr Bosch. …

[HTML][HTML] A randomized, controlled trial of oral propranolol in infantile hemangioma

…, O Boccara, R Foelster-Holst, MI Bosch… - … England Journal of …, 2015 - Mass Medical Soc
Background Oral propranolol has been used to treat complicated infantile hemangiomas,
although data from randomized, controlled trials to inform its use are limited. Methods We …

[PDF][PDF] Structural and molecular remodeling of dendritic spine substructures during long-term potentiation

M Bosch, J Castro, T Saneyoshi, H Matsuno, M Sur… - Neuron, 2014 - cell.com
Synapses store information by long-lasting modifications of their structure and molecular
composition, but the precise chronology of these changes has not been studied at single-…

Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense

M Bosch, M Sánchez-Álvarez, A Fajardo… - Science, 2020 - science.org
INTRODUCTION In all eukaryotic cells, lipid droplets (LDs) store and supply essential lipids
to produce signaling molecules, membrane building blocks, and metabolic energy. The LD …

[HTML][HTML] First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

…, TF Cloughesy, P Mulholland, ML Bosch - Journal of translational …, 2018 - Springer
Background Standard therapy for glioblastoma includes surgery, radiotherapy, and
temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed …